Carles Fernández-Jané1, Jordi Vilaró2, Yutong Fei3, Congcong Wang4, Jianping Liu5, Na Huang6, Ruyu Xia7, Xia Tian8, Ruixue Hu9, Mingkun Yu10, Natàlia Gómara-Toldrà11, Mireia Solà-Madurell12, Mercè Sitjà-Rabert13. 1. School of Health Science Blanquerna, Ramon Llull University, Barcelona, Spain; Global Research on Wellbeing (GRoW) Research Group, Ramon Llull University, Barcelona, Spain. Electronic address: carlesfj@blanquerna.url.edu. 2. School of Health Science Blanquerna, Ramon Llull University, Barcelona, Spain; Global Research on Wellbeing (GRoW) Research Group, Ramon Llull University, Barcelona, Spain. Electronic address: jordivc@blanquerna.url.edu. 3. Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China. Electronic address: yutong_fei@163.com. 4. Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China. Electronic address: wangcongcong08@sina.cn. 5. Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China. Electronic address: Jianping_l@hotmail.com. 6. Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China. Electronic address: 271064203@qq.com. 7. Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China. Electronic address: xiaruyujiayou@163.com. 8. Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China. Electronic address: 365431323@qq.com. 9. Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China. Electronic address: 15600790873@163.com. 10. Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China. Electronic address: yumingkun163@163.com. 11. School of Health Science Blanquerna, Ramon Llull University, Barcelona, Spain; Faculty of Health Science and Welfare, University of Vic, Vic, Spain. Electronic address: nataliagt@blanquerna.url.edu. 12. Residència Jaume Batlle, Pere Mata Foundation, Barcelona, Spain. Electronic address: somfisioterapia@gmail.com. 13. School of Health Science Blanquerna, Ramon Llull University, Barcelona, Spain; Global Research on Wellbeing (GRoW) Research Group, Ramon Llull University, Barcelona, Spain. Electronic address: mercesr@blanquerna.url.edu.
Abstract
BACKGROUND: This is the first part of a larger spectrum systematic review which aims to identify and evaluates the effectiveness of all different non-pharmacological acupuncture techniques used for COPD. In this first publication, we describe the results of filiform needle acupuncture METHODS: Randomised controlled trials up to May 2019 were searched in 11 databases. Data extraction and risk of bias assessment was conducted in pairs independently. RevMan 5.3 was used for the meta-analysis. RESULTS: 28 trials using filiform needle alone or in combination of other techniques were included. Compared with no acupuncture, no difference was seen for dyspnoea, but statistical benefits were found on quality of life (Std. MD: -0.62, 95%CI: -0.90, -0.34), exercise capacity (stable subgroup) (6MWT MD: 33.05 m, 95%CI: 19.11, 46.99) and lung function (FEV1% MD: 1.58, 95%CI: 0.51, 2.66). Compared with sham, statistical benefits were found on dyspnoea (Std. MD: -1.07, 95%CI: -1.58, -0.56), quality of life (Std. MD: -0.81, 95%CI: -1.12, -0.49), exercise capacity (6MWT MD: 76.68 m, 95% CI: 39.93, 113.43) and lung function (FEV1% MD: 5.40, 95%CI: 2.90, 7.91; FEV1/FVC MD: 6.64, 95%CI: 3.44, 9.83). CONCLUSIONS: Results show that filiform needle acupuncture might be beneficial for COPD, but due to the low quality of the studies this should be confirmed by future well-designed trials. PROTOCOL REGISTRATION: PROSPERO (identifier: CRD42014015074).
BACKGROUND: This is the first part of a larger spectrum systematic review which aims to identify and evaluates the effectiveness of all different non-pharmacological acupuncture techniques used for COPD. In this first publication, we describe the results of filiform needle acupuncture METHODS: Randomised controlled trials up to May 2019 were searched in 11 databases. Data extraction and risk of bias assessment was conducted in pairs independently. RevMan 5.3 was used for the meta-analysis. RESULTS: 28 trials using filiform needle alone or in combination of other techniques were included. Compared with no acupuncture, no difference was seen for dyspnoea, but statistical benefits were found on quality of life (Std. MD: -0.62, 95%CI: -0.90, -0.34), exercise capacity (stable subgroup) (6MWT MD: 33.05 m, 95%CI: 19.11, 46.99) and lung function (FEV1% MD: 1.58, 95%CI: 0.51, 2.66). Compared with sham, statistical benefits were found on dyspnoea (Std. MD: -1.07, 95%CI: -1.58, -0.56), quality of life (Std. MD: -0.81, 95%CI: -1.12, -0.49), exercise capacity (6MWT MD: 76.68 m, 95% CI: 39.93, 113.43) and lung function (FEV1% MD: 5.40, 95%CI: 2.90, 7.91; FEV1/FVC MD: 6.64, 95%CI: 3.44, 9.83). CONCLUSIONS: Results show that filiform needle acupuncture might be beneficial for COPD, but due to the low quality of the studies this should be confirmed by future well-designed trials. PROTOCOL REGISTRATION: PROSPERO (identifier: CRD42014015074).
Authors: Renato Fleury Cardoso; Ana Cristina Rodrigues Lacerda; Vanessa Pereira Lima; Lucas Fróis Fernandes de Oliveira; Sofia Fróis Fernandes de Oliveira; Rafaela Paula Araújo; Cecylia Leiber Fernandes E Castro; Flávia Pereira da Silva; Lizânia Vieira de Paiva; Lia Dietrich; Pedro Henrique Scheidt Figueiredo; Henrique Silveira Costa; Mario Bernardo-Filho; Danúbia da Cunha de Sá-Caputo; Vanessa Amaral Mendonça; Redha Taiar Journal: J Clin Med Date: 2022-05-28 Impact factor: 4.964